MM-549 Ciltacabtagene Autoleucel Vs Standard of Care in Patients with Functional High-Risk Multiple Myeloma: CARTITUDE-4 Subgroup Analysis
Clinical Lymphoma Myeloma and Leukemia(2024)
关键词
MM,Multiple myeloma,ciltacabtagene autoleucel,CAR-T therapy,functional high risk,phase 3
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要